This ICR is approved consistent with revised instruments and supporting materials and HRSA memos of 6/30/09, 8/13/09, and 8/20/09. In particular, HRSA agrees to acknowledge the exploratory and descriptive nature of these site-specific studies (and thus limitations to both their internal and external validity) in all public disclosures of study results, including the Report to Congress. HRSA also acknowledges that the exploratory nature of the study design does not enable the study sites or HRSA to infer that any results stem from the Patient Navigator programs, as more experimental study designs utilizing control groups would be necessary to draw such conclusions. Thus, HRSA will aim to avoid language that implies such causal relationships (e.g. avoiding language like "the Patient Navigator program worked"). Finally, HRSA agrees to brief OMB on the study results and how they will be presented in the Report to Congress, prior to publication. According to HRSA's timeline, HRSA will receive a draft report by the end of September, with the final report going to Congress by the end of March. HRSA should, therefore, aim to brief OMB by the end of December 2010.
Inventory as of this Action
Requested
Previously Approved
12/31/2010
36 Months From Approved
40,590
0
0
20,693
0
0
0
0
0
Six grants have been awarded to eligible entities for the development and operation of demonstration programs to provide patient navigator services to improve health careoutcomes. The Patient Navigator Outreach and Chronic Disease Prevention Demonstration Program should demonstrate how local initiatives can potentially reduce the burden of cancer and other chronic diseases such as obesity, diabetes, asthma and others by reducing the barriers related to accessing high quality health care services. This evaluation consists of two parts: 1) an evaluation of the patient navigators themselves; and 2) an evaluation of health outcomes of the patients who will be navigated.
US Code:
42 USC 256A
Name of Law: Public Health Service Act
PL:
Pub.L. 109 - 18 1812
Name of Law: Patient Navigator Outreach and Chronic Disease Prevention Demonstration Act of 2005
PL: Pub.L. 109 - 18 1812 Name of Law: Patient Navigator Outreach and Chronic Disease Prevention Demonstration Act of 2005
The Patient Navigator Outreach and Chronic Disease Prevention Demonstration Act of 2005 mandated an evaluation of the Patient Navigator Demonstration Program funded by the Health Resources and Services Administration.
$395,680
No
No
Uncollected
Uncollected
No
Uncollected
Susan Queen 3014431129
No
On behalf of this Federal agency, I certify that the collection of information encompassed by this request complies with 5 CFR 1320.9 and the related provisions of 5 CFR 1320.8(b)(3).
The following is a summary of the topics, regarding the proposed collection of information, that the certification covers:
(i) Why the information is being collected;
(ii) Use of information;
(iii) Burden estimate;
(iv) Nature of response (voluntary, required for a benefit, or mandatory);
(v) Nature and extent of confidentiality; and
(vi) Need to display currently valid OMB control number;
If you are unable to certify compliance with any of these provisions, identify the item by leaving the box unchecked and explain the reason in the Supporting Statement.
Response to OMB Comments 08_13_09_PNDP.pdf
Patient Navigator Demonstration Program Evaluation - Grantee Level